查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519474

2024-2032 年按产品和服务、样本类型、最终用户和地区分類的药物筛选市场报告

Drug Screening Market Report by Product and Service, Sample Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球药物筛选市场规模达64亿美元。毒贩和当地毒贩数量的不断增加、药物滥用案件的增加以及虚拟货币使用的增加是推动药物筛检市场成长的一些关键因素。

药物筛选市场分析：

主要市场驱动因素：对药物筛选的需求不断增加，因为它是准确的并能提供自发性的结果，这主要推动了市场的成长。此外，世界各地不断增加的药物滥用案件也推动了全球市场的发展。

主要市场趋势：将自动化、人工智慧 (AI) 和分子诊断等先进技术与药物筛选测试相结合，以简化工作流程、减少人为错误并增强测试，这是重要的关键趋势之一，支持了市场生长。

竞争格局：一些领先的药物筛选市场公司包括 Abbott Laboratories、Alfa Scientific Designs Inc.、Bio-Rad Laboratories Inc.、Dragerwerk AG & Co. KGaA、Laboratory Corporation of America Holdings、Lifeloc Technologies Inc.、Omega Laboratories Inc.。 、OraSure Technologies Inc.、Psychemedics Corporation、Quest Diagnostics Incorporated、Siemens AG 和Thermo Fisher Scientific Inc. 等。

地理趋势：根据报告，北美是最大的药物筛选市场。该地区的增长可归因于药物滥用案件的不断升级、毒贩数量的增加以及处方药黑市的增加。

挑战与机会：药物筛选市场面临着与开发准确可靠的测试、克服误报和阴性以及解决有关样本收集和测试程序的隐私和道德问题相关的障碍。机会在于整合人工智慧和机器学习等先进技术进行资料分析，以及开发便携式和即时检测设备以实现方便、快速的筛选应用。

药物筛选市场趋势：

毒品和酒精消费量增加

药物消费的增加导致对药物筛选产品的需求增加。例如，根据 2023 年欧洲毒品报告，据报导欧盟约有 8,340 万成年人 (29%) 至少使用过一次非法药物。大麻是欧洲消费的主要非法药物，根据国家调查，预计 2022 年将有 8% 的欧洲成年人使用大麻。因此，大量人口消费药物，这影响了个人的生活，并可能增加对药物筛选的需求，从而推高药物筛选市场的近期价格。此外，药物和酒精的使用不断增加以及治疗需求预计将增加对医院药物筛检的需求。例如，根据政府发布的国家统计数据。英国，2023 年 12 月、2022 年 4 月至 2023 年 3 月期间，约 290,635 名成年人获得了有关药物使用问题的支持。与前一年相比，这一数字略有上升，约 289,215 人。此外，同一消息来源称，2022 年至 2023 年接受治疗的成年人数量约为137,749 人，高于前两年的 130,490 人和 133,704 人。药物滥用人数的大幅增加预计将推动药物筛检市场需求。

政府规章

多项法律和法规要求在各个领域进行药物和酒精检测，这些法律的实施正在增加对药物筛检产品和设备的需求。例如，2022 年 11 月，联邦汽车运输安全管理局 (FMCSA) 发布了更新，概述了药物和酒精测试要求。这些规定明确了接受检测的个人、检测频率以及触发检测的情况。此外，这些法规还透过限制雇主和服务代理使用和揭露敏感的药物和酒精检测资讯来保护员工的隐私。除了监管框架外，各国政府当局也在采取措施帮助严重成瘾者和吸毒者，这进一步推动了药物筛检市场份额的成长。例如，Nasha Mukt Bharat Abhiyaan 是印度政府的一项计划，旨在透过各种活动（例如提高认识计划）接触群众并传播对药物滥用的认识。同样，加拿大政府当局也在投资反毒品战略项目，帮助吸毒成瘾者摆脱药物滥用。例如，加拿大艾伯塔省卡加利约翰霍华德协会致力于帮助13至24岁时因毒瘾而面临辍学风险的青少年。

测试技术的进步

快速检测试剂盒、实验室检测和即时护理设备等药物筛选技术的不断进步，透过提供更快、更准确和更具成本效益的筛选解决方案，进一步推动了市场成长。此外，药物筛选技术的不断改进提高了准确性和可靠性，减少了假阳性或假阴性的可能性，确保了测试结果的可信度并最大限度地减少了验证性测试的需要，从而简化了筛选过程并降低了成本。例如，2024 年 2 月，Mobile Health 在纽约诊所推出了一项新的快速药物检测服务，供雇主轻鬆筛选和僱用候选人。同样，2023 年10 月，ProciseDx Inc. 获得FDA 重新批准对阿达木单抗（Humira 和生物仿製药Amgevita）和英夫利西单抗（Remicade 和生物仿製药Inflectra 和Renflexis）进行治疗药物监测(TDM)测试。这些检测方法称为 Procise ADL 和 Procise IFX，用于对服用阿达木单抗 (ADL) 和英夫利西单抗 (IFX) 的发炎性肠道疾病 (IBD) 患者进行定量。预计新药物测试和仪器的批准增加将在未来几年推动药物筛选市场的收入。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药物筛选市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品与服务

  • 装置
    • 市场走向
    • 关键环节
      • 免疫分析仪
      • 色谱仪器
      • 呼吸分析仪
    • 市场预测
  • 快速检测设备
    • 市场走向
    • 关键环节
      • 尿液检测设备
      • 口腔液测试装置
    • 市场预测
  • 耗材
    • 市场走向
    • 关键环节
      • 检测试剂盒
      • 样品收集杯
      • 校准器和控制装置
      • 其他的
    • 市场预测
  • 实验室服务
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依样本类型

  • 尿液样本
    • 市场走向
    • 市场预测
  • 呼吸样本
    • 市场走向
    • 市场预测
  • 口腔液样本
    • 市场走向
    • 市场预测
  • 头髮样本
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 药物检测实验室
    • 市场走向
    • 市场预测
  • 工作场所
    • 市场走向
    • 市场预测
  • 戒毒治疗中心
    • 市场走向
    • 市场预测
  • 疼痛管理中心
    • 市场走向
    • 市场预测
  • 个人用户
    • 市场走向
    • 市场预测
  • 刑事司法系统和执法机构
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Alfa Scientific Designs Inc.
    • Bio-Rad Laboratories Inc.
    • Dragerwerk AG & Co. KGaA
    • Laboratory Corporation of America Holdings
    • Lifeloc Technologies Inc.
    • Omega Laboratories Inc.
    • OraSure Technologies Inc.
    • Psychemedics Corporation
    • Quest Diagnostics Incorporated
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5624

The global drug screening market size reached US$ 6.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. The growing number of drug traffickers and local dealers, rising cases of substance abuse, and increasing employment of virtual currencies represent some of the key factors driving the drug screening market growth.

Drug Screening Market Analysis:

Major Market Drivers: Increasing demand for drug screening as it is accurate and provides spontaneous results is primarily driving the growth of the market. Furthermore, the rising cases of substance abuse around the world are also propelling the global market.

Key Market Trends: The integration of advanced technologies such as automation, artificial intelligence (AI), and molecular diagnostics with drug screening tests to streamline workflows, reduce human errors, and enhance testing is acting as one of the significant key trends, bolstering the market growth.

Competitive Landscape: Some of the leading drug screening market companies include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, and Thermo Fisher Scientific Inc., among others.

Geographical Trends: According to the report, North America is the largest market for drug screening. The growth of the region can be attributed to the escalating cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs.

Challenges and Opportunities: The drug screening market faces hurdles related to the development of accurate and reliable tests, overcoming false positives and negatives, and addressing privacy and ethical concerns regarding sample collection and testing procedures. Opportunities lie in the integration of advanced technologies such as AI and machine learning for data analysis and the development of portable and point-of-care testing devices for convenient and rapid screening applications.

Drug Screening Market Trends:

Rise in Drug and Alcohol Consumption

The increasing consumption of drugs is resulting in an increased demand for drug-screening products. For instance, according to the 2023 European Drug Report, approximately 83.4 million adults (29%) in the European Union have reportedly used illicit drugs at least once. Cannabis is the predominant illicit drug consumed in Europe, with an estimated 8% of European adults using it in 2022, based on national surveys. Thus, a high number of the population consumes drugs, which impacts the lives of individuals and is likely to increase demand for drug screening, thereby bolstering the drug screening market's recent price. Additionally, the rising utilization of drugs and alcohol, along with the need for treatment, is anticipated to drive up the demand for drug screening in hospitals. For instance, as per National statistics published by GOV. UK, in December 2023, between April 2022 and March 2023, around 290,635 adults received support for substance use issues. This is a small rise compared to the previous year, around 289,215. Moreover, the same source stated that the number of adults entering treatment from 2022 to 2023 was approx. 137,749, which is higher than the previous two years' figures of 130,490 and 133,704. Such a significant rise in the number of people undergoing substance use is anticipated to propel the drug screening market demand.

Government Regulations

Several laws and regulations mandate drug and alcohol testing in various sectors, and the implementation of such laws is augmenting the demand for drug-screening products and devices. For instance, in November 2022, the Federal Motor Carrier Safety Administration (FMCSA) released updates outlining the drug and alcohol testing requirements. These regulations specify the individuals subject to testing, the frequency of testing, and the circumstances triggering testing. Additionally, the regulations safeguard employee privacy by limiting the use and disclosure of sensitive drug and alcohol testing information by employers and service agents. Besides the regulatory framework, government authorities of various nations are also taking initiatives to help severe addicts and individuals suffering from drug abuse, which is further propelling the drug screening market share. For instance, Nasha Mukt Bharat Abhiyaan is a program by the Indian Government that intends to reach out to the masses and spread awareness about substance abuse through various activities like awareness generation programs. Similarly, the government authorities of Canada are also investing in anti-drug strategy projects to help people with addiction come out of substance abuse. For example, the Calgary John Howard Society in Alberta, Canada, focuses on assisting youths aged 13 to 24 who face the risk of school dropout due to drug addiction.

Advancements in Testing Technologies

Ongoing advancements in drug screening technologies, such as rapid testing kits, laboratory-based assays, and point-of-care devices, are further driving the market growth by offering faster, more accurate, and cost-effective screening solutions. Moreover, the continuous improvement of drug screening technologies is resulting in enhanced accuracy and reliability and reduced likelihood of false positives or false negatives, ensuring confidence in test results and minimizing the need for confirmatory testing, thereby streamlining the screening process and reducing costs. For instance, in February 2024, Mobile Health introduced a new rapid drug testing service in New York clinics for employers to screen and hire candidates easily. Similarly, in October 2023, ProciseDx Inc. received de novo FDA clearance for the therapeutic drug monitoring (TDM) tests for adalimumab (Humira and biosimilar Amgevita) and infliximab (Remicade and biosimilars Inflectra and Renflexis). These assays, called Procise ADL and Procise IFX, are used to quantify adalimumab (ADL) and infliximab (IFX) in patients suffering from inflammatory bowel diseases (IBD) who are taking these drugs. Increasing approval of new drug tests and instruments is anticipated to propel the drug screening market revenue in the coming years.

Global Drug Screening Industry Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and service, sample type, and end user.

Breakup by Product and Service:

Equipment

Immunoassay Analyzers

Chromatography Instruments

Breath Analyzers

Rapid Testing Devices

Urine Testing Devices

Oral Fluid Testing Devices

Consumables

Assay Kits

Sample Collection Cups

Calibrators and Controls

Others

Laboratory Services

Rapid testing devices represented the largest segment

The drug screening market report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.

Rapid drug screening test devices are portable, easy-to-use tools designed for quick detection of drugs in various sample types, such as urine, saliva, or blood. These devices offer several benefits, including rapid results within minutes, enabling on-the-spot decision-making in scenarios like workplace testing or roadside screening. Their simplicity allows for minimal training requirements, making them accessible to a wide range of users. Moreover, rapid tests are cost-effective, reducing the need for laboratory analysis and turnaround time. For instance, Drager, a German company based in Lubeck that makes breathing and protection equipment, gas detection and analysis systems, and non-invasive patient monitoring technologies, introduced a rapid test named DrugTest 5000. In this test, saliva samples can be analyzed immediately for an accurate result on the spot. Furthermore, rapid screening devices play a crucial role in emergencies, aiding in the quick identification of drug intoxication or overdose for prompt medical intervention.

Breakup by Sample Type:

Urine Samples

Breath Samples

Oral Fluid Samples

Hair Samples

Others

Urine samples accounted for the largest market share

A detailed breakup and analysis of the drug screening market based on the sample type has also been provided in the report. This includes urine samples, breath samples, oral fluid samples, hair samples, and others. According to the report, urine samples accounted for the largest market share.

As per the drug screening market overview, urine sample drug testing offers several benefits, making it a preferred method over other sample types in many scenarios. Firstly, urine testing is non-invasive and relatively easy to collect, minimizing discomfort and ensuring employee cooperation. Secondly, urine samples can detect a wide range of drugs and their metabolites, providing comprehensive screening capabilities. Thirdly, urine testing is cost-effective and suitable for high-volume testing, making it practical for workplace screening programs. Furthermore, urine testing is capable of detecting recent drug use, making it suitable for detecting impairment in safety-sensitive industries. Lastly, this testing is less susceptible to adulteration or tampering compared to other sample types, ensuring the integrity and reliability of test results.

Breakup by End User:

Hospitals

Drug Testing Laboratories

Workplaces

Drug Treatment Centers

Pain Management Centers

Personal Users

Criminal Justice System and Law Enforcement Agencies

Workplaces accounted for the largest market share

A detailed breakup and analysis of the drug screening market based on the end user has also been provided in the report. This includes hospitals, drug testing laboratories, workplaces, drug treatment centers, pain management centers, personal users, and criminal justice system and law enforcement agencies. According to the report, workplaces accounted for the largest market share.

Drug screening tests in workplaces are conducted to detect the presence of drugs or alcohol in employees. These tests are typically performed as part of pre-employment screening, random testing, post-accident testing, or reasonable suspicion testing. The aim is to ensure a safe and productive work environment, minimize the risk of accidents and injuries, and deter substance abuse among employees.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America (the United States and Canada) was the largest market for drug screening

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening.

Some of the factors driving the North America drug screening market included the growing cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs. Moreover, drug screening market statistics by IMARC indicate that the growing substance abuse rates in the region are bolstering the need for drug screening. For instance, in February 2023, according to an article published by the Pennsylvania State University, around 63% of adults aged 18 years and above were reported to alcohol consumption in the United States in 2022. Among these, males (66%) had higher alcohol consumption as compared to females (61%). Thus, the large number of alcohol consumers raises the need for drug-testing products and services and is augmenting the market growth in North America. Moreover, the government authorities of North America are mandating drug screening tests in various sectors, which is further catalyzing the market growth. For instance, in May 2023, the United States Department of Transportation regulated the drug testing program by including oral fluid testing to improve safety and reduce the chances of cheating involved with urine drug tests.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include:

Abbott Laboratories

Alfa Scientific Designs Inc.

Bio-Rad Laboratories Inc.

Dragerwerk AG & Co. KGaA

Laboratory Corporation of America Holdings

Lifeloc Technologies Inc.

Omega Laboratories Inc.

OraSure Technologies Inc.

Psychemedics Corporation

Quest Diagnostics Incorporated

Siemens AG

Thermo Fisher Scientific Inc.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

Drug Screening Market Recent Developments:

March 2024: bioXcelerate, a new and innovative health data science division of Optima Partners Limited, revealed a groundbreaking AI tool, which is set to accelerate the process of identifying and developing new drugs. The tool, known as PleioGraph, can analyze complex medical data 100 times faster than existing state-of-the-art methods used to detect biological networks that explain disease risk and inform drug discovery.

December 2023: Quest Diagnostics, one of the leading providers of diagnostic information services, unveiled its new confirmatory testing service for novel psychoactive substances (NPS). The new panel, which tests for 88 compounds, covers a broad array of drug classes, such as designer opioids, designer benzodiazepines, designer stimulants, fentanyl analogs, synthetic cannabinoids, and other illicit additives.

October 2023: In India, Kerala police launched a rapid drug screening system that involves the utilization of a hand-held device, named the SoToxa Mobile Test System, and detects drug usage in 5 minutes.

Key Questions Answered in This Report

  • 1. What was the size of the global drug screening market in 2023?
  • 2. What is the expected growth rate of the global drug screening market during 2024-2032?
  • 3. What are the key factors driving the global drug screening market?
  • 4. What has been the impact of COVID-19 on the global drug screening market?
  • 5. What is the breakup of the global drug screening market based on the product and service?
  • 6. What is the breakup of the global drug screening market based on the sample type?
  • 7. What is the breakup of the global drug screening market based on the end user?
  • 8. What are the key regions in the global drug screening market?
  • 9. Who are the key players/companies in the global drug screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Immunoassay Analyzers
      • 6.1.2.2 Chromatography Instruments
      • 6.1.2.3 Breath Analyzers
    • 6.1.3 Market Forecast
  • 6.2 Rapid Testing Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Urine Testing Devices
      • 6.2.2.2 Oral Fluid Testing Devices
    • 6.2.3 Market Forecast
  • 6.3 Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Assay Kits
      • 6.3.2.2 Sample Collection Cups
      • 6.3.2.3 Calibrators and Controls
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Laboratory Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sample Type

  • 7.1 Urine Samples
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Breath Samples
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Oral Fluid Samples
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hair Samples
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Testing Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Workplaces
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Drug Treatment Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pain Management Centers
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Personal Users
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Criminal Justice System and Law Enforcement Agencies
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alfa Scientific Designs Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Dragerwerk AG & Co. KGaA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Laboratory Corporation of America Holdings
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Lifeloc Technologies Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Omega Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 OraSure Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Psychemedics Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Quest Diagnostics Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Siemens AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Screening Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Drug Screening Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Drug Screening Market: Breakup by Product and Service (in %), 2023
  • Figure 5: Global: Drug Screening Market: Breakup by Sample Type (in %), 2023
  • Figure 6: Global: Drug Screening Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Drug Screening Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Drug Screening (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Drug Screening (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Drug Screening (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Drug Screening (Workplaces) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Drug Screening (Personal Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Drug Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Drug Screening Industry: SWOT Analysis
  • Figure 90: Global: Drug Screening Industry: Value Chain Analysis
  • Figure 91: Global: Drug Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
  • Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million US$), 2024-2032
  • Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Drug Screening Market: Competitive Structure
  • Table 7: Global: Drug Screening Market: Key Players